, Slack and Wilkinson (1948) , Cohen (1948) , Govan and Scott (1949) , Slack and Wilkinson (1949) , Sinclair and Duthie (1949) , French (1949) , Ramsey (1950) and others, on the use of iron sucrose compound and a proprietary preparation, Ferrivenin. In the absence of any publication on this subject in this country, it was considered pertinent to und&rtake a study of intravenous iron therapy in microcytic hypochromic anaemia. [July, 1951 of these cases has been given in table I. It will be observed that the maximum increase in both red cells and haemoglobin occurred in the third week. Other toxic reactions were very uncommon.
The side effects were commonly met with during the first few injections. Utilization is however interfered in the presence of infection as was found in case 11. In contrast to the poor and unreliable uptake of oral iron from gastro-intestinal tract, Hahn and AVhipple (1938) Lehmann (1949) . Wintrobe (1946) and Govan and Scott (1949) have shown that the increase in MCV on iron treatment coincides with the reticulocyte response, like pernicious ansemia cases on treatment with liver (Wintrobe, 1934 
